STRO
Sutro Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
STRO fundamentals
Sutro Biopharma (STRO) released its earnings on Aug 7, 2025: revenue was 63.74M (YoY +147.96%), beat estimates; EPS was -0.14 (YoY +76.27%), beat estimates.
Revenue / YoY
63.74M
+147.96%
EPS / YoY
-0.14
+76.27%
Report date
Aug 7, 2025
Earnings Call
4:00 PM on Aug 7, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
STRO has released its 2025 Q3 earnings report, with revenue of 9.69M, reflecting a YoY change of 13.77%, and net profit of -56.86M, showing a YoY change of -16.54%. The Sankey diagram below clearly presents STRO's revenue sources and cost distribution.
Key Indicators
Sutro Biopharma (STRO) key financial stats and ratios, covering profitability, financial health, and leverage.
Sutro Biopharma (STRO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Sutro Biopharma (STRO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Sutro Biopharma (STRO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Sutro Biopharma (STRO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Sutro Biopharma (STRO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Sutro Biopharma's management provide for the next earnings period?What were the key takeaways from Sutro Biopharma's earnings call?What is the revenue and EPS growth rate for Sutro Biopharma year over year?Did Sutro Biopharma beat or miss consensus estimates last quarter?What is Sutro Biopharma's latest dividend and current dividend yield?What factors drove the changes in Sutro Biopharma's revenue and profit?What is the market's earnings forecast for Sutro Biopharma next quarter?What were the key takeaways from Sutro Biopharma’s earnings call?
